Bausch + Lomb will hold an investor day on Thursday, Nov. 13, 2025, where the company will provide a business update and highlight its innovative product pipeline. Additional details will follow ...

About Bausch + Lomb Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life.

VAUGHAN, Ontario, July 01, 2025--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today launched "Eyes Tell ...

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its second-quarter financial results on ...

Eyecare company Bausch + Lomb priced its initial public offering late Thursday at $18 a share, below the expected range of $21 to $24, after a day of carnage in stock markets that saw major ...

Patients exploring options for cataract surgery or Custom Lens Replacement now have access to one of the most advanced intraocular lenses available—the Bausch + Lomb enVista Envy lens—offered ...

Learn about the executive team and board of directors at Bausch & Lomb Corp (BLCO:XNYS) and review their bios and compensation over the latest fiscal years.